US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
The United States influenza vaccines market size is anticipated to observe tremendous growth projections during 2019 – 2025.
The prominent factors that are expected to contribute to the growth of the US Influenza vaccines market during the forecast period:
Increased Disease Awareness
Approval/launches of the New Influenza Vaccines
Expanded Recommendations by Governmental and Advisory Bodies to be Vaccinated against Influenza Vaccines
Introduction of the Quadrivalent Influenza Vaccines
Highlighted with 17 tables and 16 figures, this 145-page report “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” is based on comprehensive research of the entire United States influenza vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States influenza vaccines market. The report provides historical market data for 2013 – 2018, and forecasts from 2019 till 2025.
The report contains a deep analysis of the US influenza vaccines market with size in terms of both value and volume of the US influenza vaccines market. The report provides clear insight into current and future developments of the United States influenza vaccines market. The report also explores detailed analysis of the children and adults vaccinated with influenza vaccines in United States from 2013 to 2018 and forecasts to 2025. The report also details the latest information about the influenza vaccines production, supply, and allocation by major companies in the United States.
A comprehensive analysis has been done on pricing, distribution & demand and effectiveness of the influenza vaccines in the United States. It also provides a deep and thorough evaluation of the distribution channel and technique of the influenza vaccination. Furthermore, this topical report describes the features reimbursement pattern and offers a clear view of the regulatory framework. Additionally, the report comprises assessment of clinical trials, reviews promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2025.
The report also provides comprehensive profiles of the dominant players in the country’s influenza vaccines market such as Seqirus, Sanofi Pasteur, GlaxoSmithKline (GSK) and AstraZeneca with important details on companies’ vaccines portfolio, sales, strategies, and the latest developments. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, and Biondvax Pharmaceuticals Ltd, are making novel technology-based influenza vaccines which are likely to affect the market share during the forecast period.
Key Topics Covered in the Report:
The Market Size of the United States Influenza Vaccines Market
Scrutinizes the US Overall Persons Being Vaccinated with Influenza Vaccines
Scrutinizes the US Children Being Vaccinated with Influenza Vaccines
Scrutinizes the US Adults Being Vaccinated with Influenza Vaccines
Provides Comprehensive Insights on the Latest Pricing Trends and Analysis
Includes a Detailed Analysis of the US Influenza Vaccines Production, Supply, and Allocation (By Companies)
Delivers a Complete Overview of the US Influenza Vaccines Distribution and Demand
Examines the Effectiveness of the Influenza Vaccines in the United States
Detailed Assessment of the Rapid Diagnostic Testing for the Management of Influenza
Thoroughly Evaluates of the Distribution Channel and Technique of the Influenza Vaccination in the United States
Detailed Insights of the Regulatory Framework, Features Reimbursement Patterns of the US Influenza Vaccines
Provides Key Trends with Respect to Collaboration, Merger & Acquisition, Distribution, Exclusive and Licensing Agreement
An Insightful Analysis of the Promising Influenza Vaccines in the Clinical Development
Reviews Most Recent Clinical Trials of the Influenza Vaccines
Investigates the Key Growth Drivers and Restraints of the US Influenza Vaccines Market
A Comprehensive List of Key Market Players Along with the Analysis of their Current Vaccines Portfolios, Sales Value Analysis, and Recent Development
The Report Helps Answer the Following Questions:
What is the size of the influenza vaccines market in the United States?
How many persons being vaccinated with influenza vaccines in the US during 2013 – 2025?
What are the key drivers and restraints in the current market?
What are the various influenza vaccines available in the United States?
How is the market predicted to develop in the future?
Who are the key players in this market space?
Key Topics Covered
1. Executive Summary
2. United States Influenza Vaccines Market Size & Analysis (2013 – 2025)
3. United States Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
3.1 Number of Children Vaccinated with Influenza Vaccines
3.2 Number of Adults Vaccinated with Influenza Vaccines
4. Key Drivers and Inhibitors of the United States Influenza Vaccines Market
4.1 Market Drivers
4.2 Market Restraints
5. United States Influenza Vaccines Pricing Trends & Analysis
6. United States Influenza Vaccines Production, Supply, and Allocation (By Companies)
7. United States Influenza Vaccines Distribution & Demand (2010 – 2019)
8. Effectiveness of Influenza Vaccines in the United States (2004 – 2019)
9. Rapid Diagnostic Testing for the Management of Influenza
10. Distribution Channel & Technique of Influenza Vaccination in United States
11. United States Influenza Vaccines Reimbursement Policies & Regulatory System
11.1 Reimbursement Policies
11.2 Regulation System
12. Major Deals in the Influenza Vaccines Market
12.1 Merger & Acquisitions
12.2 Collaboration Deal
12.3 Licensing Agreement
12.4 Exclusive Agreement
12.5 Distribution Agreement
13. Promising Influenza Vaccines in the Clinical Development
14. Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
14.1 Year 2018
14.2 Year 2017
15. Key Companies Analysis
The report is readily available and can be dispatched immediately after payment confirmation.
More Information @
Would like to place an order or any question, please feel free to contact at email@example.com
Customization of the Report:
DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.
Head of Business Development
DPI Research | Web: https://dpiresearch.com
Direct Line: +91-766-764-8693
DPI Research is a leading market research publisher which offer bespoke market research reports, custom research and consulting services across multi geographies and industry verticals. We deliver a wide range of cutting-edge research solutions that help organizations in making better decisions of the business to business needs.
DPI Research provides a high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to using advanced analytical tools and methodologies to help clients with crucial industry information for decision making.
DPI Research approaches for business research led by a team of dynamic industry experts. DPI Research provides real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reaches across the globe with global standards from established markets in North America and Europe to emerging markets in South America, Asia-Pacific, Middle East, and Africa to provide the best business solutions.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Flu Vaccine [Influenza Vaccine] Market Research Report 2020 here
News-ID: 1893408 • Views: 916
More Releases from DPI Research
U.S. CGM Market Analysis Detailed Growth Outlook, New Developments, Upcoming Ind …
The United States Continuous Glucose Monitoring market analysis offered by DPI Research scrutinizes key growth factors that are impacting sales in the market. The report offers in-depth insights covering key factors such as drivers, opportunities, key players' strategies, and demand outlook for the CGM market. In addition to this, the study analyzes latest trends across various segments including product type and end use. Amid the COVID-19 crisis, the United States Continuous
United States Human Vaccines Market Worth US$ 31 Billion by 2028 | CAGR 7%
According to DPI Research Amid the COVID-19 crisis, the United States human vaccines market is poised to grow by US$ 31,517 million by 2028, accelerating at a CAGR of 7% during the forecast period. 𝗚𝗲𝘁 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗣𝗗𝗙 𝗦𝗮𝗺𝗽𝗹𝗲 𝗮𝘁- https://dpiresearch.com/request-a-free-sample-reports/ The prominent factors that are expected to contribute to the growth of the United States human vaccines market: Increased Disease Awareness Approval/launches of the New Vaccines Rising Focus on Immunization Programs Increasing Investments
South Korea E-Commerce Market and Forecast 2022 - 2028 | Exclusive Report by DPI …
DPI Research recently published a report, titled, "South Korea E-Commerce Market and Forecast 2022 - 2028" As per the report, "South Korea E-Commerce market size is expected to reach US$ 156 Billion by 2028" "South Korea E-Commerce Market and Forecast 2022 - 2028" provides a comprehensive analysis of the fast-evolving, high-growth e-commerce market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the
U.S. Online Grocery Market Accelerating at a CAGR of 14.1% to Touch a Value of U …
Amid the COVID-19 crisis, the United States market for online grocery estimated at US$ 96 billion in the year 2021, is expected to reach a revised market size of US$ 242 billion by 2028, growing at a CAGR of 14.1% over the period 2021 - 2028. The Prominent Factors that are Expected to Contribute to the Growth of the United States Online Grocery Market During the Forecast Period: changing lifestyle of the
More Releases for Influenza
H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,
Influenza Vaccine Market | DPIResearch.com
According to the DPI Research new growth forecast report titled “Worldwide Influenza Vaccines Market Size | Forecast to 2027” to Witness Comprehensive Growth by 2027 DPI Research published a new report on Worldwide Influenza Vaccines Market. The research offers an extensive analysis of key players active in the Worldwide Influenza Vaccines Market. Detailed analysis on operating business segments, product portfolio, business performance, and key strategic developments is offered in the research.
Influenza Drugs and Vaccines Market describes its growth, size, share, Forecast and trends to 2025 Influenza Drugs and Vaccines Market Production and Demand Analysis 2019 to 2025 Influenza Drugs and Vaccines Market 2019 Manufacturing Analysis and Development Forecast 2025 Influenza Drugs and Vaccines Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Influenza Drugs and Vaccines Market to Insight By 2025: Top Key Vendors Influenza Drugs and Vaccines Market Insights 2019, Global and
The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In European Ma …
Europe Influenza Market Influenza is an upper respiratory tract disease and is caused by the influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children less than five years of age. The infection may be confirmed by testing
The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In U.S. Market
Influenza is an upper respiratory tract disease and is caused by the Influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children with less than 5 years of age. The infection may be confirmed by testing the
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about